Literature DB >> 29558108

Effects of Nanoprobe Morphology on Cellular Binding and Inflammatory Responses: Hyaluronan-Conjugated Magnetic Nanoworms for Magnetic Resonance Imaging of Atherosclerotic Plaques.

Seyedmehdi Hossaini Nasr, Anne Tonson, Mohammad H El-Dakdouki1, David C Zhu, Dalen Agnew, Robert Wiseman, Chunqi Qian, Xuefei Huang.   

Abstract

Atherosclerosis is an inflammatory disease of arterial walls and the rupturing of atherosclerotic plaques is a major cause of heart attack and stroke. Imaging techniques that can enable the detection of atherosclerotic plaques before clinical manifestation are urgently needed. Magnetic resonance imaging (MRI) is a powerful technique to image the morphology of atherosclerotic plaques. In order to better analyze molecular processes in plaques, contrast agents that can selectively bind to plaque receptors will prove invaluable. CD44 is a cell surface protein overexpressed in plaque tissues, the level of which can be correlated with the risks of plaque rupture. Thus, targeting CD44 is an attractive strategy for detection of atherosclerotic plaques. Herein, we report the synthesis of hyaluronan-conjugated iron oxide nanoworms (HA-NWs). A new purification and gel electrophoresis protocol was developed to ensure the complete removal of free HA from HA-NWs. Compared to the more traditional spherical HA-bearing nanoparticles, HA-NWs had an elongated shape, which interacted much stronger with CD44-expressing cells in CD44- and HA-dependent manners. Furthermore, the HA-NWs did not induce much inflammatory response compared to the spherical HA nanoparticles. When assessed in vivo, HA-NWs enabled successful imaging of atherosclerotic plaques in a clinically relevant model of ApoE knockout transgenic mice for noninvasive plaque detection by MRI. Thus, nanoprobe shape engineering can be a useful strategy to significantly enhance their desired biological properties.

Entities:  

Keywords:  ApoE knockout mice; atherosclerosis; hyaluronan; magnetic resonance imaging; nanoworms

Mesh:

Substances:

Year:  2018        PMID: 29558108      PMCID: PMC5995107          DOI: 10.1021/acsami.7b19708

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  68 in total

Review 1.  Hyaluronan: from extracellular glue to pericellular cue.

Authors:  Bryan P Toole
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

2.  Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells.

Authors:  Mohammad H El-Dakdouki; David C Zhu; Kheireddine El-Boubbou; Medha Kamat; Jianjun Chen; Wei Li; Xuefei Huang
Journal:  Biomacromolecules       Date:  2012-03-13       Impact factor: 6.988

Review 3.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

Review 4.  The importance of nanoparticle shape in cancer drug delivery.

Authors:  Nghia P Truong; Michael R Whittaker; Catherine W Mak; Thomas P Davis
Journal:  Expert Opin Drug Deliv       Date:  2014-08-20       Impact factor: 6.648

5.  Receptor-targeted iron oxide nanoparticles for molecular MR imaging of inflamed atherosclerotic plaques.

Authors:  Chuqiao Tu; Thomas S C Ng; Hargun K Sohi; Heather A Palko; Adrian House; Russell E Jacobs; Angelique Y Louie
Journal:  Biomaterials       Date:  2011-07-13       Impact factor: 12.479

6.  Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse.

Authors:  M E Rosenfeld; P Polinsky; R Virmani; K Kauser; G Rubanyi; S M Schwartz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

7.  Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis.

Authors:  Matthias Nahrendorf; Farouc A Jaffer; Kimberly A Kelly; David E Sosnovik; Elena Aikawa; Peter Libby; Ralph Weissleder
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

8.  CD44 Antibody Inhibition of Macrophage Phagocytosis Targets Fcγ Receptor- and Complement Receptor 3-Dependent Mechanisms.

Authors:  Alaa Amash; Lin Wang; Yawen Wang; Varsha Bhakta; Gregory D Fairn; Ming Hou; Jun Peng; William P Sheffield; Alan H Lazarus
Journal:  J Immunol       Date:  2016-03-04       Impact factor: 5.422

9.  Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.

Authors:  G S Abela; P D Picon; S E Friedl; O C Gebara; A Miyamoto; M Federman; G H Tofler; J E Muller
Journal:  Circulation       Date:  1995-02-01       Impact factor: 29.690

10.  Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI).

Authors:  Bryan R Smith; Johannes Heverhagen; Michael Knopp; Petra Schmalbrock; John Shapiro; Masashi Shiomi; Nicanor I Moldovan; Mauro Ferrari; Stephen C Lee
Journal:  Biomed Microdevices       Date:  2007-10       Impact factor: 2.838

View more
  5 in total

1.  Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles.

Authors:  Seyedmehdi Hossaini Nasr; Zahra Rashidijahanabad; Sherif Ramadan; Nate Kauffman; Narayanan Parameswaran; Kurt R Zinn; Chunqi Qian; Ripla Arora; Dalen Agnew; Xuefei Huang
Journal:  Nanoscale       Date:  2020-05-07       Impact factor: 7.790

Review 2.  Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering.

Authors:  Ralf P Friedrich; Iwona Cicha; Christoph Alexiou
Journal:  Nanomaterials (Basel)       Date:  2021-09-08       Impact factor: 5.719

Review 3.  Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.

Authors:  Jun Chen; Xixi Zhang; Reid Millican; Jennifer Sherwood; Sean Martin; Hanjoong Jo; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Adv Drug Deliv Rev       Date:  2021-01-09       Impact factor: 15.470

4.  Co-Delivery of Curcumin and Paclitaxel by "Core-Shell" Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer.

Authors:  Meng-Dan Zhao; Jun-Qin Li; Feng-Ying Chen; Wei Dong; Li-Juan Wen; Wei-Dong Fei; Xiao Zhang; Pei-Lei Yang; Xin-Mei Zhang; Cai-Hong Zheng
Journal:  Int J Nanomedicine       Date:  2019-12-02

Review 5.  Nanoparticle-Based Approaches towards the Treatment of Atherosclerosis.

Authors:  Artur Y Prilepskii; Nikita S Serov; Daniil V Kladko; Vladimir V Vinogradov
Journal:  Pharmaceutics       Date:  2020-11-05       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.